New Enterprise Associates 16, L.P. Trevi Therapeutics, Inc. (TRVI) insider trading activity

New Enterprise Associates 16, L.P. is > 10% Shareholder of Trevi Therapeutics, Inc.. Currently has a direct ownership of 10.4 Million shares of TRVI, which is worth approximately $42.7 Million. The most recent transaction as insider was on Apr 11, 2022, when has been sold 2,631,578 shares (Common Stock) at a price of $1.9 per share, resulting in proceeds of $4,999,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.4M

0% 3M change

0% 12M change

Total Value Held $42.7 Million

New Enterprise Associates 16, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Apr 11 2022	BUY Open market or private purchase	$4,999,998 $1.9 p/Share	2,631,578 Added 20.16%	10,421,428 Common Stock
Oct 18 2021	BUY Open market or private purchase	-	1,851,852 Added 19.21%	7,789,850 Common Stock

Also insider at

BHG

Bright Health Group Inc. Healthcare

MRKR

Marker Therapeutics, Inc. Healthcare

MTCR

Metacrine, Inc. Healthcare

> 10% Shareholder

GNCA

GENOCEA BIOSCIENCES, INC. Healthcare

> 10% Shareholder

AKUS

Akouos, Inc. Healthcare

> 10% Shareholder

MIRM

Mirum Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

NEA